Cardiovascular Diseases Clinical Trial
To improve the predictive validity of Structured Interview assessments of Type A behavior by comparing interviewer techniques in the Multiple Risk Factor Intervention Trial (MRFIT) and the Western Collaborative Group Study (WCGS). To assess whether there were interviewer differences in the predictiveness of Type A behavior and its components for coronary heart disease incidence in MRFIT and WCGS and if so, to assess whether the interviewer differences in disease predictiveness were related to interviewer stylistics.
BACKGROUND:
Individuals with Type A behavior are characterized as hard driving, competitive, and time
urgent; when asked questions they are quick to answer with emphatic speech; they perceive
themselves to be striving and competing and are prone to hostility. This core of behaviors
is presumed to be on a continuum of intensity with well-developed Type A's at the upper end
and well-developed Type B's at the lower end. Epidemiological studies have shown Type A's to
have a higher prevalence and incidence of various forms of coronary heart disease than Type
B's. The Structured Interview is a method of measuring Type A behavior in which a series of
questions are administered about the individual's characteristic responses to situations
relevant to the Type A behavior pattern, such as reaction to delay and reported frequency of
anger. The Interview is delivered in challenging style designed to elicit Type A
characteristics.
In 1960, the WCGS recruited 3,154 employed men, ages 39 to 59, who were initially free of
coronary heart disease and followed them for 8.5 years for coronary heart disease incidence.
In 1972 MRFIT began recruiting 12,866 men, ages 35 to 57, selected for elevation of one or
more risk factors, but free from coronary heart disease and followed them for an average of
seven years after randomization to a risk factor modification group or to a control group
referred to their own physicians for treatment. Both studies used the Structured Interview
to assess Type A behavior.
In 1981, Type A behavior was officially regarded as an independent risk factor for coronary
heart disease, based largely on the findings of the WCGS. However, the MRFIT did not find
Type A behavior to be related to coronary heart disease incidence. The manner of conducting
the Structured Interview may have affected the predictive reliability of the Type A
assessments.
DESIGN NARRATIVE:
Interviewer speech characteristics from the WCGS and MRFIT Structured Interview tape
recordings were audited and analyzed. Each speech characteristic was scored with high
reliability. Multiple logistic regression analyses were used to control for standard risk
factors.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|